Cabergoline for preventing ovarian hyperstimulation syndrome.

Cochrane database of systematic reviews (Online)

Volumn 2, Issue , 2012, Pages

  Tang, Huilin ^a   Hunter, Tamara ^b   Hu, Yongfang ^b   Zhai, Suo Di ^b   Sheng, Xiaoyan ^b   Hart, Roger J ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOLINE DERIVATIVE;

FEMALE; HUMAN; INFERTILITY THERAPY; META ANALYSIS; ORAL DRUG ADMINISTRATION; OVARY HYPERSTIMULATION; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADMINISTRATION, ORAL; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84861306253     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (0)